Stay updated on Pediatric Tolerability of Xerecept in Clinical Trial
Sign up to get notified when there's something new on the Pediatric Tolerability of Xerecept in Clinical Trial page.

Latest updates to the Pediatric Tolerability of Xerecept in Clinical Trial page
- Check5 days agoChange DetectedA consolidated Locations section now lists Illinois and Massachusetts as study sites, replacing separate 'Illinois Locations' and 'Massachusetts Locations' entries. The HHS Vulnerability Disclosure link was removed and the revision updated to v3.3.3.SummaryDifference0.4%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing the previous v3.2.0.SummaryDifference0.1%

- Check41 days agoChange DetectedDeleted administrative notice about government funding and operating status. Study details, contacts, and eligibility criteria remain unchanged.SummaryDifference0.4%

- Check55 days agoChange DetectedUpdates to the Study Details page include revised eligibility criteria, primary completion date, and study design details.SummaryDifference0.4%

- Check84 days agoChange DetectedCore content updated to reflect current operating status and a new version (v3.2.0) while removing the old version label (v3.1.0).SummaryDifference5%

- Check91 days agoChange Detected- Updated the page version from v3.0.2 to v3.1.0. Minor overall impact, mainly reflects a version increment.SummaryDifference0.1%

Stay in the know with updates to Pediatric Tolerability of Xerecept in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Tolerability of Xerecept in Clinical Trial page.